期刊文献+

VEGF和BMP-2在骨肉瘤组织中的表达及临床意义 被引量:1

Expression of VEGF and BMP-2 in osteosarcoma tissue and its clinical significance
下载PDF
导出
摘要 目的:探索VEGF和BMP-2在骨肉瘤组织中的表达与骨肉瘤的诊断、转移复发及预后的关系。方法:应用免疫组织化学法(S-P法)检测41例骨肉瘤组织中VEGF、BMP-2及CD34的表达,计算微血管密度(MVD),并综合分析所有病例资料。结果:41例骨肉瘤患者中,VEGF及BMP-2阳性表达率分别为68.2%(28/41)和61.0%(25/41),与肿瘤大小、Price’s分级、Dahlin’s组织学分型等无关(P>0.05)。VEGF阳性组BMP-2阳性率及MVD(分别为75%和40.25±8.02)与阴性组BMP-2阳性率及MVD(分别为30.8%和15.54±5.87)相比,差异有显著意义(P<0.05)。复发或转移组VEGF及BMP-2的阳性率(分别为92.9%和85.7%)明显高于无复发或转移组的VEGF及BMP-2的阳性率(分别为55.6%和48.1%),差异具有显著意义(P<0.05)。VEGF及BMP-2阳性组的5年存活率(分别为7.1%和4%)明显低于VEGF及BMP-2阴性组的5年存活率(分别为46.2%和43.8%),差异有显著意义(P<0.05)。结论:VEGF、BMP-2在骨肉瘤组织中呈高表达,VEGF的表达与BMP-2的表达及MVD显著相关,检测VEGF、BMP-2的表达和MVD值可以作为判断骨肉瘤转移复发和预后的重要指标。 Objective:To explore the expression of VEGF and BMP-2 in osteosarcoma tissue and its association with diagnosis,metastasis/recurrence and prognosis of osteosarcoma.Methods:Immunohistochemical staining(SP method)was used to detect the expression of VEGF,BMP-2 and CD34 in specimens from 41 cases of osteosarcoma.Microvessel density was calculated,and overall information of all the 41 cases were analyzed.Results:In 41 cases,the positive rates of VEGF and BMP-2 were 68.2%(28/41)and 61.0%(25/41)respectively.The expression of VEGF and BMP-2 were not significantly correlated to tumor's size,Price's grade and Dahlin's difierentiation(P〉0.05).The positive rate of BMP-2 and MVD(75% and 40.25±8.02)in VEGF positive patients were respectively much higher than those(30.8%and 15.54±5.87)in VEGF negative patients(P〈0.05).The positive rates of VEGF and BMP-2(92.9%and 85.7%)in patients with metastasis / recurrence were respectively remarkably higher than those(55.6% and 48.1%)in patients without metastasis/recurrence(P〈0.05).The five-year survival rate in patients with positive expression of VEGF and BMP-2(7.1%and 4%)were significantly lower than that(46.2%and 43.8%)in negative control group(P〈0.05).Conclusion:High expression of VEGF and BMP-2 were found in osteosarcoma tissue.The expression of VEGF was closely correlated to the expression of BMP-2 and MVD.Detection of VEGF and BMP-2 expression and MVD may be useful for judging metastasis/recurrence and prognosis of osteosarcoma.
出处 《重庆医科大学学报》 CAS CSCD 北大核心 2009年第8期1042-1046,共5页 Journal of Chongqing Medical University
关键词 骨肉瘤 VEGF BMP-2 免疫组织化学 Osteosarcoma VEGF BMP-2 Immunohistochemistry
  • 相关文献

参考文献14

  • 1Warzecha J,Gottig S,Chow K U,et al.Inhibition of osteosarcoma cell proliferation by the Hedge hog-inhibitor cyclopamine[J].J Chemother,2007,19(5):554-561.
  • 2Shintani K,Matsumine A,Kusuzaki K,et al.Decorin suppresses lung metastases of murine osteosarcoma[J]Oncol Rep,2008,19(6):1533-1539.
  • 3Raspollini M R,Amunni G,Villanucci A,et al.Prognostic significance of microvessel density and vascular endothelial growth factor expression in advanced serous carcinoma[J].Int J Gynecol Cancer,2004,14(5):815-823.
  • 4王东,仲召阳,李增鹏,张沁宏,何怡,卿毅.骨肉瘤VEGF表达及VEGF抗体抑制血管生成的实验研究[J].重庆医学,2006,35(15):1369-1372. 被引量:4
  • 5Mei J,Gao Y,Zhang L,et al.VEGF-siRNA silencing induces apoptosis,inhibits proliferation and suppresses vasculogenic mimicry in osteosarcoma in vitro[J].Exp Oncol,2008,30(1):29-34.
  • 6Kaya M,Wada T,Akatsuka T,et al.Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis[J].Clin Cancer Res,2000,6(2):572-577.
  • 7Khan S A,Nelson M S,Pan C,et al.Endogenous heparan sulfate and heparin modulate bone morphogenetic protein-4 signaling and activity[J].Am J Physiol Cell Physiol,2008,294(6):C1387-1397.
  • 8Jorgensen N R,Henriksen Z,Sorensen O H,et al.Dexamethasone,BMP-2 and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype:validation of an in vitro model for human bone marrow-derived primary osteoblasts[J].Steroids,2004,69(4):219-226.
  • 9Sotobori T,Ueda T,Myoui A,et al.Bone morphogenetic protein-2promotes the haptotaetic migration of murine ostooblasfic and osteosarcoma cells by enhancing incorporation of integrin betal into lipid rafts[J].ExpCell Res,2006,312(19):3927-3938.
  • 10ArihiroK,Inai K.Expression of CD31,Met/hepatocyte gowth factor receptor and bone morphogenetic protein in bone metastasis of osteosarcoma[J].Pathol Int,2001,51(2):100-106.

二级参考文献11

  • 1付生法,陆应麟,张朝山,陈坤.检测血管生长因子作用的鸡胚绒毛尿囊膜技术[J].军事医学科学院院刊,1993,17(4):294-297. 被引量:129
  • 2Lee SJ,Lee SY,Jeon HS,et al.Vascular endothelial growth factor gene polymorphisms and risk of primary lung cancer[J].Cancer Epidemiol Biomarkers Prev,2005,14(3):571
  • 3Riedel F,Gotte K,Hormann K,et al.Antiangiogenic therapy of head and neck squamous cell carcinoma by vascular endothelial growth factor antisense therapy[J].Adv Otorhinolaryngol,2005,62:103
  • 4Gaiddon C,Moorthy NC,Prirs C.Ref-1 regulates the transactivation and pro-apoptotic functions of p53 in vivo[J].EMBO,1999,18:5609
  • 5Hicklin DJ,Ellis LM.Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis[J].J Clin Oncol,2005,23(5):1011
  • 6Takano S,Kamiyama H,Tsuboi K,et al.Angiogenesis and antiangiogenic therapy for malignant gliomas[J].Brain Tumor Pathol,2004,21:69
  • 7Ellis LM.Preclinical data targeting vascular endothelial growth factor in colorectal cancer[J].Clin Colorectal Cancer,2004,4:S55
  • 8Zheng WQ,Zhan RZ.Quantitative comparision to cell proliferation and p53 protein in breast cancer[J].Anal Quant Cytol Histol,1998,20:1
  • 9Schoeffner DJ,Matheny SL,Akahane T,et al.VEGF contributes to mammary tumor growth in transgenic mice through paracrine and autocrine mechanisms[J].Lab Invest,2005,85(5):608
  • 10Huh JI,Calvo A,Stafford J,et al.Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms[J].Oncogene,2005,27(24):790

共引文献3

同被引文献19

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部